Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole in Refractory Fungal Infections
NCT00550732Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2007
- Primary completion
- Nov 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of posaconazole in invasive fungal infection (IFI), sponsored by Merck & Co.. Started Dec 2007; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00550732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550732.